FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051278614> ?p ?o ?g. }

• W2051278614 endingPage "1298" @default.
• W2051278614 startingPage "1293" @default.
• W2051278614 abstract "Background & Aims Various vasoconstrictors are useful in the management of hepatorenal syndrome (HRS). Terlipressin is the drug of choice; however, it is expensive. In this study, we evaluated safety and efficacy of terlipressin and noradrenaline in the treatment of HRS. Methods Forty-six patients with HRS type 1 were managed with terlipressin (group A, N = 23) or noradrenaline (Group B, N = 23) with albumin in a randomized controlled trial at a tertiary center. Results HRS reversal could be achieved in 9 (39.1%) patients in group A and 10 (43.4%) patients in group B (p = 0.764). Univariate analysis showed baseline Child Turcotte Pugh score (CTP), model of end stage liver disease (MELD), urine output on day 1(D1), albumin, and mean arterial pressure (MAP) were associated with response. However, on multivariate analysis only CTP score was associated with response. Fourteen patients in group A and 12 in group B died at day 15 (p >0.05). Noradrenaline was less expensive than terlipressin (p <0.05). No major adverse effects were seen. Conclusions The results of this randomized study suggest that noradrenaline is as safe and effective as terlipressin, but less expensive in the treatment of HRS and baseline CTP score is predictive of response. Various vasoconstrictors are useful in the management of hepatorenal syndrome (HRS). Terlipressin is the drug of choice; however, it is expensive. In this study, we evaluated safety and efficacy of terlipressin and noradrenaline in the treatment of HRS. Forty-six patients with HRS type 1 were managed with terlipressin (group A, N = 23) or noradrenaline (Group B, N = 23) with albumin in a randomized controlled trial at a tertiary center. HRS reversal could be achieved in 9 (39.1%) patients in group A and 10 (43.4%) patients in group B (p = 0.764). Univariate analysis showed baseline Child Turcotte Pugh score (CTP), model of end stage liver disease (MELD), urine output on day 1(D1), albumin, and mean arterial pressure (MAP) were associated with response. However, on multivariate analysis only CTP score was associated with response. Fourteen patients in group A and 12 in group B died at day 15 (p >0.05). Noradrenaline was less expensive than terlipressin (p <0.05). No major adverse effects were seen. The results of this randomized study suggest that noradrenaline is as safe and effective as terlipressin, but less expensive in the treatment of HRS and baseline CTP score is predictive of response." @default.
• W2051278614 created "2016-06-24" @default.
• W2051278614 creator A5007660487 @default.
• W2051278614 creator A5010678013 @default.
• W2051278614 creator A5016501797 @default.
• W2051278614 creator A5036410096 @default.
• W2051278614 creator A5038267980 @default.
• W2051278614 creator A5040682018 @default.
• W2051278614 creator A5047048765 @default.
• W2051278614 creator A5077943551 @default.
• W2051278614 creator A5087291567 @default.
• W2051278614 creator A5088580305 @default.
• W2051278614 date "2012-06-01" @default.
• W2051278614 modified "2023-10-13" @default.
• W2051278614 title "Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study" @default.
• W2051278614 cites W1967589221 @default.
• W2051278614 cites W1988741645 @default.
• W2051278614 cites W1990867757 @default.
• W2051278614 cites W2022683720 @default.
• W2051278614 cites W2033110222 @default.
• W2051278614 cites W2036652612 @default.
• W2051278614 cites W2045376161 @default.
• W2051278614 cites W2045620941 @default.
• W2051278614 cites W2045627721 @default.
• W2051278614 cites W2066442380 @default.
• W2051278614 cites W2068351869 @default.
• W2051278614 cites W2074466817 @default.
• W2051278614 cites W2079304328 @default.
• W2051278614 cites W2087450723 @default.
• W2051278614 cites W2094598763 @default.
• W2051278614 cites W2105682288 @default.
• W2051278614 cites W2112088795 @default.
• W2051278614 cites W2113711610 @default.
• W2051278614 cites W2131903288 @default.
• W2051278614 cites W2132058135 @default.
• W2051278614 cites W2155487694 @default.
• W2051278614 cites W2164601307 @default.
• W2051278614 cites W2166775393 @default.
• W2051278614 cites W2214600008 @default.
• W2051278614 cites W2316957914 @default.
• W2051278614 cites W4255387568 @default.
• W2051278614 doi "https://doi.org/10.1016/j.jhep.2012.01.012" @default.
• W2051278614 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22322237" @default.
• W2051278614 hasPublicationYear "2012" @default.
• W2051278614 type Work @default.
• W2051278614 sameAs 2051278614 @default.
• W2051278614 citedByCount "216" @default.
• W2051278614 countsByYear W20512786142012 @default.
• W2051278614 countsByYear W20512786142013 @default.
• W2051278614 countsByYear W20512786142014 @default.
• W2051278614 countsByYear W20512786142015 @default.
• W2051278614 countsByYear W20512786142016 @default.
• W2051278614 countsByYear W20512786142017 @default.
• W2051278614 countsByYear W20512786142018 @default.
• W2051278614 countsByYear W20512786142019 @default.
• W2051278614 countsByYear W20512786142020 @default.
• W2051278614 countsByYear W20512786142021 @default.
• W2051278614 countsByYear W20512786142022 @default.
• W2051278614 countsByYear W20512786142023 @default.
• W2051278614 crossrefType "journal-article" @default.
• W2051278614 hasAuthorship W2051278614A5007660487 @default.
• W2051278614 hasAuthorship W2051278614A5010678013 @default.
• W2051278614 hasAuthorship W2051278614A5016501797 @default.
• W2051278614 hasAuthorship W2051278614A5036410096 @default.
• W2051278614 hasAuthorship W2051278614A5038267980 @default.
• W2051278614 hasAuthorship W2051278614A5040682018 @default.
• W2051278614 hasAuthorship W2051278614A5047048765 @default.
• W2051278614 hasAuthorship W2051278614A5077943551 @default.
• W2051278614 hasAuthorship W2051278614A5087291567 @default.
• W2051278614 hasAuthorship W2051278614A5088580305 @default.
• W2051278614 hasConcept C126322002 @default.
• W2051278614 hasConcept C144301174 @default.
• W2051278614 hasConcept C168563851 @default.
• W2051278614 hasConcept C197934379 @default.
• W2051278614 hasConcept C2776988256 @default.
• W2051278614 hasConcept C2777214474 @default.
• W2051278614 hasConcept C2779393834 @default.
• W2051278614 hasConcept C38180746 @default.
• W2051278614 hasConcept C71924100 @default.
• W2051278614 hasConcept C90924648 @default.
• W2051278614 hasConceptScore W2051278614C126322002 @default.
• W2051278614 hasConceptScore W2051278614C144301174 @default.
• W2051278614 hasConceptScore W2051278614C168563851 @default.
• W2051278614 hasConceptScore W2051278614C197934379 @default.
• W2051278614 hasConceptScore W2051278614C2776988256 @default.
• W2051278614 hasConceptScore W2051278614C2777214474 @default.
• W2051278614 hasConceptScore W2051278614C2779393834 @default.
• W2051278614 hasConceptScore W2051278614C38180746 @default.
• W2051278614 hasConceptScore W2051278614C71924100 @default.
• W2051278614 hasConceptScore W2051278614C90924648 @default.
• W2051278614 hasIssue "6" @default.
• W2051278614 hasLocation W20512786141 @default.
• W2051278614 hasLocation W20512786142 @default.
• W2051278614 hasOpenAccess W2051278614 @default.
• W2051278614 hasPrimaryLocation W20512786141 @default.
• W2051278614 hasRelatedWork W2036652612 @default.
• W2051278614 hasRelatedWork W2065074119 @default.
• W2051278614 hasRelatedWork W2170493680 @default.

• next